TASK DEFINITION: Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
PROBLEM: Paragraph: Swedish Thunberg said on Instagram she had now recovered from symptoms milder than her latest cold, and may not have suspected COVID-19 had it not been for her father, who had travelled with her, developing more severe symptoms. "Many (especially young people) might not notice any symptoms at all, or very mild symptoms. Then they don't know they have the virus and can pass it on to people in risk groups," she said. "We who don't belong to a risk group have an enormous responsibility, our actions can be the difference between life and death for many others. Please keep that in mind, follow the advice from experts and your local authorities and #StayAtHome to slow the spread of the virus." The founder of the Fridays for Future youth movement said she had not been tested for the virus but given the combined symptoms and circumstances it was very likely she had it. She had self isolated because she had visited countries hit by coronavirus infection. Fridays for Future calls on politicians to listen to climate scientists and take urgent action to against global warming. Claim: Greta Thunberg says probably had COVID-19, urges #StayAtHome.

SOLUTION: Teen climate activist Greta Thunberg said on Tuesday that while self-isolating after recent travels in Europe she probably came down with COVID-19, and urged other young people to stay at home too if even just a little unwell, to help stop the coronavirus.

PROBLEM: Paragraph: "Cost data for flibanserin is not provided. Some projection of cost should be available for any drug this far along in Phase III trials and for which the company has already begun marketing campaigns. If not from the company, then from stock analysts. The story properly quantifies the reportedbenefits in absolute terms which allows the reader to see that they are small. (Results aredescribed inQuality of Evidence comments.) Inaninterview a study researcher conceded that the absolute number of women reporting benefit was not large. The storyprovided statistics on common side effects includingdaytime sleepiness, dizziness, fatigue, anxiety, dry mouth, nausea and insomnia. These side effects resulted in 15% of thosetaking flibanserin vs 7% taking placebo withdrawing from the study. The story does a good job of presenting and evaluating the available evidence. Results are presented in absolute terms, for example that just under one third of women taking flibanserin reported improvement in sexual distress/desire compared to approximately one fifth of women taking placebo. In contrast,these results were presented in relative terms by the manufacturer. Except for the headline,"" 'Female Viagra' May Treat Low Sexual Desire"",this storyavoidsdisease mongeringand notes that""hypoactive sexual desire disorder"" in women is a controversial diagnosis. The text clarifies that while the popular press isdubbing flibanserin as the ""female Viagra"", it is not similar to Viagra or other drugs to treat erectile dysfunction. Conflicts of interest are disclosed. The story noted that the study researcherinterviewed is a paid consultant for the drug manufacturer. An alternative point of view is provided bytwo independent experts, apsychologist and a sex-therapist. The independent sources comment on the role that personal relationships play in sexual desire and experience which was not addressed or acknowledged by the researchers. The story indicates thatan alternative drug called the Intrinsa testosterone patchis available in Europe, but not in the U.S. The story also notes a difference betweenthese dugs; Intrinsais a hormonal treatment compared to flibanserin which is a non-hormonal. The story indirectly informs that reader that flibanserin is not available by noting that it is in phase III clinical trials and that the manufactureris seeking FDA approval (despite early direct to consumer marketing campaigns). The story makes it fairly clear that this is a new treatment also for a new and controversial diagnosis. The story was apparently based onresearch presented in abstract format the annual clinical meeting of the American College of Gynecologists and Obstetricians, although this informationhas not beenpublished in independently, peer-referred scientific journals. There is no direct evidence that it relied largely on a news release. In fact, the use of interviews with independent experts makes it clear that independent reporting took place." Claim: 'Female Viagra' May Treat Low Sexual Desire

SOLUTION: "This story reports on a investigational drug, flibanserin, that is being developed to treat what is a controversial diagnosiscalled ""hypoactive sexual desire"" in women. The popular press has dubbed this drug ""Female Viagra"" despite that fact that it has few similarities to drugs that treat erectile dysfunction. Preliminary research examining the drug's efficacy in treating sexual distress and/or low sexual desire were presented at the May 2010 annual clinical meeting of the American College of Obstetricians and Gynecologists (ACOG). To place the story in context, previous reports from the manufacturerclaimed thatflibanserin resulted in""clinically significant""improvementin the number of sexually satisfying events reported by women taking the drug vs. those taking placebo, an absolute difference of 0.7 events per month. The story was detailed and did a good job of presentinginformation in absolute terms so that the reader could clearly see that reported benefits were small and of unknownclinical significance. Good reminders that this is a controversial diagnosis and that ""some experts see it as the medicalization of what is for many women a relationship issue."""

PROBLEM: Paragraph: Two Oregon wineries stepped in to buy the grapes, but getting the Oregon Solidarity wines they produced to markets on time is in doubt because the federal agency that approves labels has a huge backlog, a hangover from the government shutdown. Nationwide, makers of alcoholic drinks face disrupted business and lost revenue. If another shutdown starts in about two weeks, as President Donald Trump has threatened if Congress doesn't provide money for a border wall, the backlog could persist. U.S. Sen. Ron Wyden and U.S. Rep. Earl Blumenauer, both Oregon Democrats, warned of "disastrous" consequences in a letter to John Manfreda, administrator of the U.S. Alcohol and Tobacco Tax and Trade Bureau. They urged Manfreda to dedicate all resources to clearing the backlog of applications. "This regulatory paralysis disproportionately disadvantages small, craft brewers, vintners, cider makers, and distillers, who depend on new product releases for their businesses' survival," Wyden and Blumenauer said Tuesday. Michael Kaiser, vice president of WineAmerica, a national association of U.S. wineries, said the backlog will also stretch the turnaround time on new applications to around 36 days. The federal alcohol agency strives for it to be two to four days. It must issue permits for beverages that will be sold across state lines and approve the labels. "This will impact wineries of all size," Kaiser said in an email. California winery Copper Cane canceled contracts last fall to buy 2,000 tons (1,814 metric tons) of grapes, saying lab testing showed smoke taint after wildfires last year cloaked much of Oregon in smoke and ash. Jim Blumling, Copper Cane's vice president of operations, has said both lab and sensory tests showed a high level of smoke taint and that the most effective time to test is as close as possible to harvest. But independent laboratory analysis showed much of the crop was not adversely affected, the local wineries said. Willamette Valley Vineyards head winemaker Joe Ibrahim had sampled a few of the grapes, searching for an ashy taste in the skins that would reveal some taint. He found none. "The wines are actually really beautiful wines," Ibrahim said, standing next to a huge vat in his winery's cellar containing rose of pinot noir, the first of the three Oregon Solidarity wines that will be bottled. The vineyard outside the small town of Turner and King Estate Winery in Eugene bought 150 tons (136 metric tons) of the grapes, enough to produce 88,800 bottles of wine. Eyrie Vineyards and Silvan Ridge Winery helped make the wines. Willamette Valley and King Estate would have bought even more grapes, but they were already getting overripe on the vine, Willamette winery director Christine Collier Clair said. One grower also had crop insurance for 1,500 tons (1,360 metric tons), she said. The label application for the rose was sent and approved before the government shutdown, Clair said. The federal agency still must approve labels for Oregon Solidarity chardonnay and pinot noir. Retailers are counting on having the wines and to do promotions, she said. The wines will be sold nationwide and will be available to buy online. Rogue Valley Vintners, a southern Oregon nonprofit made up of wine producers, growers and community partners, will get the proceeds. Clair said she hopes the chardonnay label gets approved on time for its scheduled May release. Alcohol and Tobacco Tax and Trade Bureau spokesman Thomas Hogue said there are many applications to wade through. "We are still assessing the workload," Hogue said in an email Monday, when federal employees returned to work after five weeks. "I think it's safe to say that our backlog has roughly doubled as a result of the shutdown." ___ Follow Andrew Selsky on Twitter at https://twitter.com/andrewselsky Claim: Shutdown casts pall on effort to help Oregon winegrowers.

SOLUTION:
Winegrowers in southern Oregon faced financial ruin after a California winemaker claimed wildfire smoke tainted their grapes and refused to buy them. Now, the rejected fruit that was turned into wine by local vintners is facing another setback.